HSIC vs TECH
Henry Schein Inc (HSIC) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported HSIC revenue for 2024-12-28 was $12.67B. Net income was $398.0M. Revenue was up 2.7% from 2023-12-30 to 2024-12-28. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the HSIC and TECH stock pages for the full models.
Not investment advice.